Evotec Competitors
| EVO Stock | USD 3.40 0.01 0.29% |
Evotec SE vs Pacira BioSciences Correlation
Pay attention - limited upside
The correlation between Evotec SE ADR and PCRX is -0.74 (i.e., Pay attention - limited upside) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Evotec SE ADR and PCRX in the same portfolio, assuming nothing else is changed.
Moving together with Evotec Stock
Moving against Evotec Stock
As of the 28th of February 2026, Return On Tangible Assets is likely to drop to -0.12. In addition to that, Return On Capital Employed is likely to drop to -0.09. At this time, Evotec SE's Intangibles To Total Assets are very stable compared to the past year.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Evotec SE's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Evotec SE Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Evotec SE and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Evotec and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Evotec SE ADR does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Evotec Stock performing well and Evotec SE Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Evotec SE's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TLRY | 4.69 | 0.07 | 0.00 | 1.04 | 5.60 | 7.64 | 54.17 | |||
| AZTA | 2.16 | (0.43) | 0.00 | (0.24) | 0.00 | 3.81 | 29.88 | |||
| NVCR | 3.56 | 0.18 | 0.06 | 0.16 | 4.22 | 6.92 | 35.96 | |||
| SYRE | 2.78 | 0.86 | 0.31 | 0.94 | 2.30 | 8.27 | 20.03 | |||
| TDOC | 2.51 | (0.54) | 0.00 | (0.18) | 0.00 | 4.72 | 15.93 | |||
| HROW | 2.56 | 0.40 | 0.15 | 0.29 | 2.64 | 6.42 | 19.18 | |||
| PHVS | 2.91 | 0.20 | 0.06 | 0.27 | 3.37 | 5.78 | 27.81 | |||
| ALVO | 2.68 | (0.38) | 0.00 | (0.57) | 0.00 | 6.42 | 16.71 | |||
| SDGR | 2.51 | (0.58) | 0.00 | (0.21) | 0.00 | 4.42 | 21.90 | |||
| PCRX | 2.01 | (0.11) | 0.00 | (0.07) | 0.00 | 3.14 | 12.33 |
Cross Equities Net Income Analysis
Compare Evotec SE ADR and related stocks such as Tilray Inc, Azenta Inc, and Novocure Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TLRY | (96.4 K) | (96.4 K) | (42 K) | (42 K) | (5.3 M) | 305.1 K | 3.1 M | 22.8 M | (25 M) | (102.5 M) | (443.7 M) | (601 M) | (2 B) | (333.8 M) | (3 B) | (2.7 B) | (2.6 B) |
| AZTA | 1.5 M | 136.8 M | (2.2 M) | 4.5 M | 14.2 M | (69.5 M) | 62.6 M | 116.6 M | 28.8 M | 64.9 M | 110.7 M | (429 M) | (14.3 M) | (164.9 M) | (55.8 M) | (64.1 M) | (67.3 M) |
| NVCR | (77.4 M) | (77.4 M) | (77.4 M) | (77.4 M) | (80.7 M) | (111.6 M) | (131.8 M) | (61.7 M) | (63.6 M) | (7.2 M) | 19.8 M | (58.4 M) | (92.5 M) | (207 M) | (168.6 M) | (136.2 M) | (143 M) |
| SYRE | (10.3 M) | (10.3 M) | (10.3 M) | (10.3 M) | (10.3 M) | (11.3 M) | (21.7 M) | (27.2 M) | (44.3 M) | (78.3 M) | (80.9 M) | (65.8 M) | (83.8 M) | (338.8 M) | (208 M) | (155.2 M) | (147.4 M) |
| TDOC | (6 M) | (6 M) | (6 M) | (6 M) | (17 M) | (58 M) | (74.2 M) | (106.8 M) | (97.1 M) | (98.9 M) | (485.1 M) | (428.8 M) | (13.7 B) | (220.4 M) | (1 B) | (200.3 M) | (210.3 M) |
| HROW | (46.2 K) | (954 K) | (5.4 M) | (7.6 M) | (10.1 M) | (15.9 M) | (19.1 M) | (12 M) | 14.6 M | 168 K | (3.4 M) | (18 M) | (14.1 M) | (24.4 M) | (17.5 M) | (15.7 M) | (14.9 M) |
| PHVS | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (9 M) | (29.6 M) | (42.7 M) | (76.3 M) | (100.9 M) | (134.2 M) | (120.8 M) | (114.8 M) |
| ALVO | (209.9 M) | (209.9 M) | (209.9 M) | (209.9 M) | (209.9 M) | (209.9 M) | (209.9 M) | (209.9 M) | (209.9 M) | (209.9 M) | (170 M) | (101.5 M) | (513.6 M) | (551.7 M) | (231.9 M) | (208.7 M) | (219.1 M) |
| SDGR | (17.4 M) | (17.4 M) | (17.4 M) | (17.4 M) | (17.4 M) | (17.4 M) | (17.4 M) | (17.4 M) | (28.4 M) | (24.6 M) | (24.5 M) | (100.4 M) | (149.2 M) | 40.7 M | (187.1 M) | (103.3 M) | (108.4 M) |
| PCRX | (41.9 M) | (43.3 M) | (52.3 M) | (63.9 M) | (13.7 M) | 1.9 M | (37.9 M) | (42.6 M) | (471 K) | (11 M) | 145.5 M | 42 M | 15.9 M | 42 M | (99.6 M) | 26.7 M | 28 M |
Evotec SE ADR and related stocks such as Tilray Inc, Azenta Inc, and Novocure Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Evotec SE ADR financial statement analysis. It represents the amount of money remaining after all of Evotec SE ADR operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Evotec SE Competitive Analysis
The better you understand Evotec SE competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Evotec SE's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Evotec SE's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Evotec SE Competition Performance Charts
Five steps to successful analysis of Evotec SE Competition
Evotec SE's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Evotec SE ADR in relation to its competition. Evotec SE's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Evotec SE in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Evotec SE's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Evotec SE ADR, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Evotec SE position
In addition to having Evotec SE in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Global Macro ETFs Thematic Idea Now
Global Macro ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Global Macro ETFs theme has 33 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Global Macro ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Evotec SE Correlation with its peers. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Will Biotechnology sector continue expanding? Could Evotec diversify its offerings? Factors like these will boost the valuation of Evotec SE. Projected growth potential of Evotec fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Evotec SE data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.53) | Revenue Per Share | Quarterly Revenue Growth (0.11) | Return On Assets | Return On Equity |
Understanding Evotec SE ADR requires distinguishing between market price and book value, where the latter reflects Evotec's accounting equity. The concept of intrinsic value - what Evotec SE's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Evotec SE's price substantially above or below its fundamental value.
It's important to distinguish between Evotec SE's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Evotec SE should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Evotec SE's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.